98%
921
2 minutes
20
Background: Despite the tremendous progress recently reported in ECG imaging (ECGI), some fundamental challenges are still hindering this non-invasive technology from meeting rising clinical expectations. In the present work, we address one of the major ECGI shortcomings in reconstruction of ventricular activation - the limited accuracy of endocardial and particularly septal mapping.
Methods: Ten CRT patients (five female, median (min-max) age - 61 (27-78) years) with previously implanted CRT devices underwent ECGI with isolated right ventricular (RV) pacing. In eight patients, the RV pacemaker lead was placed in the middle septal area of the posterior RV wall. Two subjects had a pacing lead in the anteroseptal apical segment, two at septal RVOT, two at septal junction with posterior wall and six in anterolateral segments. Lead positions were exactly known from CT scans, making the respective paced ECG sequences ideal for validation of ECGI endocardial accuracy. Non-invasive mapping was performed for single RV paced beats using original parameters of the CRT device. For non-invasive estimation of the focal origins, we considered the lead-field based fastest route algorithm (FRA) and its combination with the cardiac vector fit (FRA-V). Furthermore, we extended the resulting combined map by incorporating cardiac activation direction (FRA-V-D) provided by the cardiac dipole.
Results: The median (min-max) localization errors were 14 mm (7-27), 9 mm (7-28) and 11 mm (8-24) for FRA, FRA-V and FRA-V-D, respectively. Notably, in all cases at least one of the considered ECGI methods was able to correctly localize the found excitation origin on the endocardium.
Conclusions: This preliminary study investigates combination of the rule-based fastest route algorithm with cardiac vector fit and direction for non-invasive imaging of septal ventricular sources. The developed ECGI methodology delivers reasonable reconstruction accuracy with the 10 mm median localization error. These findings suggest potential use of ECGI for challenging clinical cases, where catheter access to the correct cardiac anatomical region plays a crucial role in the execution of the electrophysiological procedure.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jelectrocard.2019.08.003 | DOI Listing |
Stem Cell Res
September 2025
Basic Medical Research Center, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325035 Zhejiang, China. Electronic address:
PHD finger protein 19 (PHF19) is a polycomb protein that promoted cardiac hypertrophy via epigenetic targeting SIRT2. To determine the role of PHF19 in myocardial hypertrophy, we established a large fragment knockout model of PHF19 gene in human embryonic stem cells (hESCs-H7) using the CRISPR/Cas9 system based on a vector. This PHF19-KO cell line has a normal karyotype, classical human pluripotent stem cell morphology, strong pluripotency, and significantly reduced PHF19 gene expression, which will become a useful tool for further in-depth research on the pathogenesis of PHF19 gene deficiency induced myocardial hypertrophy.
View Article and Find Full Text PDFPLoS Comput Biol
September 2025
Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Tarnowskie Góry, Poland.
Schizophrenia and bipolar disorder are severe mental illnesses that significantly impact quality of life. These disorders are associated with autonomic nervous system dysfunction, which can be assessed through heart activity analysis. Heart rate variability (HRV) has shown promise as a potential biomarker for diagnostic support and early screening of those conditions.
View Article and Find Full Text PDFFront Med (Lausanne)
August 2025
School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Background: Older surgical patients present with diverse clinical profiles, yet research indicates a significant correlation between sarcopenia-related features and the incidence of perioperative neurocognitive disorder (PND). The integration of machine learning techniques offers a promising avenue for identifying older surgical patients at elevated risk of PND, particularly those exhibiting sarcopenia-associated characteristics. This approach enhances preoperative risk stratification and patient selection, thereby improving the precision of clinical management and treatment decisions.
View Article and Find Full Text PDFCirc Res
September 2025
Department of Cell Biology and Anatomy, Cardiovascular Translational Research Center, School of Medicine Columbia, University of South Carolina. (L.P., E.W.W., T.J.C., M.T.F., C.G.M., C.F.W.).
Background: Small artery remodeling and endothelial dysfunction are hallmarks of hypertension. Evidence supports a likely causal association between cardiovascular diseases and endothelial-to-mesenchymal transition, a cellular transdifferentiation process in which endothelial cells (ECs) partially lose their identity and acquire mesenchymal phenotypes. EC reprogramming represents an innovative strategy in regenerative medicine to prevent deleterious effects induced by cardiovascular diseases.
View Article and Find Full Text PDFInt J Cardiovasc Imaging
September 2025
Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.
Purpose: In patients with non-ST-segment elevation acute coronary syndrome (NSTEACS), coronary pathology ranges from normal vessels to severe obstructive disease. In NSTEACS patients where invasive coronary angiography (ICA) is recommended, it is unknown whether a non-invasive coronary computed tomography angiography (CCTA) may be used for patient triage. The Very Early Computerized Tomography to Organize Revascularization in patients with NSTEACS (VECTOR) study was a pilot study that assessed whether CCTA can be used to safely discharge NSTEACS patients without obstructive coronary artery disease.
View Article and Find Full Text PDF